These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17535994)

  • 1. The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma.
    Giannini R; Ugolini C; Lupi C; Proietti A; Elisei R; Salvatore G; Berti P; Materazzi G; Miccoli P; Santoro M; Basolo F
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3511-6. PubMed ID: 17535994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci.
    Park SY; Park YJ; Lee YJ; Lee HS; Choi SH; Choe G; Jang HC; Park SH; Park DJ; Cho BY
    Cancer; 2006 Oct; 107(8):1831-8. PubMed ID: 16983703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentric occurrence of multiple papillary thyroid carcinomas--HUMARA and BRAF mutation analysis.
    Nakazawa T; Kondo T; Tahara I; Kasai K; Inoue T; Oishi N; Mochizuki K; Kubota T; Katoh R
    Cancer Med; 2015 Aug; 4(8):1272-80. PubMed ID: 25882744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.
    Lupi C; Giannini R; Ugolini C; Proietti A; Berti P; Minuto M; Materazzi G; Elisei R; Santoro M; Miccoli P; Basolo F
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4085-90. PubMed ID: 17785355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone.
    Jovanovic L; Delahunt B; McIver B; Eberhardt NL; Grebe SK
    J Pathol; 2008 Jun; 215(2):145-54. PubMed ID: 18393366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status.
    Abrosimov A; Saenko V; Rogounovitch T; Namba H; Lushnikov E; Mitsutake N; Yamashita S
    Int J Cancer; 2007 Jan; 120(1):196-200. PubMed ID: 17044028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.
    Shattuck TM; Westra WH; Ladenson PW; Arnold A
    N Engl J Med; 2005 Jun; 352(23):2406-12. PubMed ID: 15944425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of multifocal papillary thyroid carcinoma.
    Lin X; Finkelstein SD; Zhu B; Silverman JF
    J Mol Endocrinol; 2008 Oct; 41(4):195-203. PubMed ID: 18628356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.
    Fugazzola L; Puxeddu E; Avenia N; Romei C; Cirello V; Cavaliere A; Faviana P; Mannavola D; Moretti S; Rossi S; Sculli M; Bottici V; Beck-Peccoz P; Pacini F; Pinchera A; Santeusanio F; Elisei R
    Endocr Relat Cancer; 2006 Jun; 13(2):455-64. PubMed ID: 16728573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L; Shindo M; Schuff K; Corless C
    Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes.
    Vasko V; Hu S; Wu G; Xing JC; Larin A; Savchenko V; Trink B; Xing M
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5265-9. PubMed ID: 15998781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
    Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.
    Liu RT; Chen YJ; Chou FF; Li CL; Wu WL; Tsai PC; Huang CC; Cheng JT
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):461-6. PubMed ID: 16181240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
    Trovisco V; Vieira de Castro I; Soares P; Máximo V; Silva P; Magalhães J; Abrosimov A; Guiu XM; Sobrinho-Simões M
    J Pathol; 2004 Feb; 202(2):247-51. PubMed ID: 14743508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF genetic heterogeneity in papillary thyroid carcinoma and its metastasis.
    Walts AE; Pao A; Sacks W; Bose S
    Hum Pathol; 2014 May; 45(5):935-41. PubMed ID: 24746198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An investigation of BRAF mutation in papillary thyroid carcinoma and its clinical value].
    Gong RX; Zhou Y; Luo SH; Zhang L; Zhou B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):310-3. PubMed ID: 19504446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma.
    Bansal M; Gandhi M; Ferris RL; Nikiforova MN; Yip L; Carty SE; Nikiforov YE
    Am J Surg Pathol; 2013 Oct; 37(10):1586-91. PubMed ID: 23797723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of BRAF and NRAS mutations in the primary tumor and metastases of papillary thyroid carcinomas.
    Cañadas-Garre M; Becerra-Massare P; Moreno Casares A; Calleja-Hernández MÁ; Llamas-Elvira JM
    Head Neck; 2016 Dec; 38(12):1772-1779. PubMed ID: 27299298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma.
    Guerra A; Sapio MR; Marotta V; Campanile E; Rossi S; Forno I; Fugazzola L; Budillon A; Moccia T; Fenzi G; Vitale M
    J Clin Endocrinol Metab; 2012 Feb; 97(2):517-24. PubMed ID: 22170714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.